Transcriptional silencing of the p16 gene in human myeloma-derived cell lines by hypermethylation

British Journal of Haematology

Volumn 103, Issue 1, 1998, Pages 168-175

  Wong, Ivy H N ^a   Ng, Margaret H L ^a,b   Lee, Joseph C K ^a   Lo, Kwok Wai ^a   Chung, Yuk Fei ^a   Huang, Dolly P ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Methylation; Multiple myeloma; p15; p16; Transcriptional block

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; PROTEIN P15; PROTEIN P16; UNCLASSIFIED DRUG;

ARTICLE; BINDING SITE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; METHYLATION; MYELOMA CELL; PRIORITY JOURNAL; SILENCER GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

BLOTTING, SOUTHERN; CELL CYCLE PROTEINS; CYCLIN-DEPENDENT KINASE INHIBITOR P15; DNA METHYLATION; DNA, NEOPLASM; GENES, P16; HUMANS; MULTIPLE MYELOMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0031657575     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Barletta, J.M., Rainier, S. & Feinberg, A.P. (1997) Reversal of loss of imprinting in tumor cells by 5-aza-2′-deoxycytidine. Cancer Research, 57, 48-50.
2. Batova, A., Diccianni, M.B., Yu, J.C., Nobori, T., Link, M.P., Pullen, J. & Yu, A.L. (1997) Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Cancer Research, 57, 832-856.
3. Cairns, P., Mao, L., Merlo, A., Lee, D., Schwab, D., Eby, Y., Tokino, K., van der Riet, P., Blaugrund, J.E. & Sidransky, D. (1994) Rates of p16(MTS1) mutations in primary tumors with 9p loss. Science, 265, 415-416.
4. Cayuela, J.M., Madani, A., Sanhes, L., Stern, M.H. & Sigaux, F. (1996) Multiple tumor-suppressor gene 1 inactivation is the most frequent genetic alteration in T-cell acute lymphoblastic leukemia. Blood, 87, 2180-2186.
5. Cheng, J.Q., Jhanwar, S.C., Klein, W.M., Bell, D.W., Lee, W.C., Altomare, D.A., Nobori, T., Olopade, O.I., Buckler, A.J. & Testa, J.R. (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Research, 54, 5547-5551.
6. Chomczynski, P. & Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry, 162, 156-159.
7. Ewen, M.E., Sluss, H.K., Sherr, C.J., Matsushime, H., Kato, J. & Livingston, D.M. (1993) Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell, 73, 487-497.
8. Gonzalgo, M.L., Bender, C.M., You, E.H., Glendening, M., Flores, J.F., Walker, G.J., Hayward, N.K., Jones, P.A. & Fountain, J.W. (1997) Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Research, 57, 5336-5347.
9. Gould, J., Alexanian, R., Goodacre, A., Pathak, S., Hecht, B. & Barlogie, B. (1988) Plasma cell karyotype in multiple myeloma. Blood, 71, 453-456.
10. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371, 257-261.
11. INK4B1. Cancer Research, 56, 722-727.
12. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J-P.J., Davidson, N.E., Sidransky, D. & Baylin, S.B. (1995) Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research, 54, 4525-4530.
13. Iravani, M., Dhat, R. & Price, C.M. (1997) Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia. Oncogene, 15, 2609-2614.
14. Jen, J., Harper, J.W., Bigner, S.H., Bigner, D.D., Papadopoulos, N., Markowitz, S., Willson, J.K.V., Kinzler, K.W. & Vogelstein, B. (1994) Deletion of p16 and p15 genes in brain tumors. Cancer Research, 54, 6353-6358.
15. Jones, P.A. (1996) DNA methylation errors and cancer. Cancer Research, 56, 2463-2467.
16. Kamb, A., Gruis, N.A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S.V., Stockert, E., Day, R.S., III, Johnson, B.E. & Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
17. Kato, J., Matsushime, H., Hiebert, S.W., Ewen, M.E. & Sherr, C.J. (1993) Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes and Development, 7, 331-342.
18. Kees, U.R., Burton, P.R., Lu, C. & Baker, D.L. (1997) Homozygous deletion of the p16/ MTS1 gene in pediatric acute lymphoblastic leukemia is associated with unfavorable clinical outcome. Blood, 89, 4161-4166.
19. Kees, U.R., Ranford, P.R. & Hatzis, M. (1996) Deletions of the p16 gene in pediatric leukemia and corresponding cell lines. Oncogene, 12, 2235-2239.
20. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. & Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nature Medicine, 1, 686-692.
21. Momparler, R.L., Bouchard, J., Onetto, N. & Rivard, G.E. (1984) 5-aza-2′-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation. Leukemia Research, 8, 181-185.
22. Momparler, R.L., Bouffard, D.Y., Momparler, L.F., Dionne, J., Belanger, K. & Ayoub, J. (1997) Pilot phase I-II study on 5-aza-2′-deoxycytidine (Decitabine) in patients with metastatic lung cancer. Anticancer Drugs, 8, 358-368.
23. Momparler, R.L., Rivard, G.E. & Gyer, M. (1985) Clinical trial on 5-aza-2′-deoxycytidine in patients with acute leukaemia. Pharmacology and Therapeutics, 30, 277-286.
24. Ng, M.H.L., Chung, Y.F., Lo, K.W. Wickham, N.W.R., Lee, J.C.K. & Huang, D.P. (1997) Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood, 89, 2500-2506.
25. Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K. & Carson, D.A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
26. Ogawa, S., Hangaishi, A., Miyawaki, S., Hirosawa, S., Miura, Y., Takeyama, K., Kamada, N., Ohtake, S., Uike, N., Shimazaki, C., Toyama, K., Hirano, M., Mizoguchi, H., Kobayashi, Y., Furusawa, S., Saito, M., Emi, N., Yazaki, Y., Ueda, R. & Hirai, H. (1995) Loss of the cyclin-dependent kinase 4-inhibitor (p16: MTS1) gene is frequent in and highly specific to lymphoid tumors in primary human hematopoietic malignancies. Blood, 86, 1548-1556.
27. Ohnishi, H., Kawamura, M., Ida, K., Sheng, X.M., Hanada, R., Nobori, T., Yamamori, S. & Hayashi, Y. (1995) Homozygous deletions of p16/MTS1 gene are frequent but mutations are infrequent in childhood T-cell acute lymphoblastic leukemia. Blood, 86, 1269-1275.
28. Ohta, M., Nagai, H., Shimizu, M., Rasio, D., Berd, D., Mastrangelo, M., Singh, A.D., Shields, J.A., Shields, C.L., Croce, C.M. & Huebner, K. (1994) Rarity of somatic and germline mutations of the cyclin-dependent kinase 4 inhibitor gene, CDK4I, in melanoma. Cancer Research, 54, 5269-5272.
29. INK4b/MTS2 in pediatric acute lymphoblastic leukemia. Blood, 85, 2321-2330.
30. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J.L., Bauters, F., Wattel, E. & Fenaux, P. (1995) p16 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85, 657-663.
31. Serrano, M., Hannon, G.J. & Beach, D. (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/ CDK4. Nature, 366, 704-707.
32. Spruck, C.H., III, Gonzalez-Zulueta, M., Shibata, A., Simoneau, A.R., Lin, M.F., Gonzales, F., Tsal, Y.C. & Jones, P.A. (1994) p16 gene in uncultured tumours. Nature, 370, 183-184.
33. Stranks, G., Height, S.E., Mitchell, P., Jadayel, D., Yuille, M.A.R., De Lord, C., Clutterbuck, R.D., Treleaven, J.G., Powles, R.L., Nacheva, E., Oscier, D.G., Karpas, A., Lenoir, G.M., Smith, S.D., Millar, K.L., Catovsky, D. & Dyer, M.J.S. (1995) Deletions and rearrangement of CDKN2 in lymphoid malignancy. Blood, 85, 893-901.
34. Takeuchi, S., Bartram, C.R., Seriu, T., Miller, C.W., Tobler, A., Janssen, J.W., Reiter, A., Ludwig, W.D., Zimmermann, M. & Schwaller, J. (1995) Analysis of a family of cyclin-dependent kinase inhibitors: p15/MTS2/INK4B, p16/MTS1/INK4A, and p18 genes in acute lymphoblastic leukemia of childhood. Blood, 86, 755-760.
35. Van den Berghe, H. (1989) Chromosomes in plasma-cell malignancies. European Journal of Haematology, 43, (Suppl. 51), 47-51.
36. ink4) in human breast carcinomas. Cancer Research, 54, 5262-5264.
37. Yamada, Y., Hatta, Y., Murata, K., Sugawara, K., Ikeda, S., Mine, M., Maeda, T., Hirakata, Y., Kamihira, S., Tsukasaki, K., Ogawa, S., Hirai, H., Koeffler, H.P. & Tomonaga, M. (1997) Deletions of p15 and/or p16 gene as a poor-prognosis factor in adult T-cell leukemia. Journal of Clinical Oncology, 15, 1778-1785.
38. Yeager, T., Stadler, W., Belair, C., Puthenveettil, J., Olopade, O. & Reznikoff, C. (1995) Increased p16 levels correlate with pRb alterations in human urothelial cells. Cancer Research, 55, 493-497.